Video

Integrating (177Lu)–PSMA-617: A Practical Approach for Urology Clinics VL

Search

Integration of Lutetium-177 and the Value of Shared Decisions with Practice Stakeholders - Jeffrey Zemencik Details Phillip Koo interviews Jeffrey Zemencik about the challenges and considerations of integrating the PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) treatment into large urology practices. Mr. Zemencik emphasizes the importance of a multi-disciplinary approach, involving stakeholders from various departments like operations and revenue cycle. He underscores the billing and reimbursement guide prov...
Expanding the Nuclear Hot Lab to Accommodate Lutetium-177 - Lyanne Gomez Details Phillip Koo tours the "hot lab" at an infusion center, guided by Lyanne Gomez, a nuclear medicine technologist. The conversation provides an in-depth look at the equipment used for handling PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan). Lyanne explains the functions of existing equipment, such as the wipe calibrator and dose calibrator. She also introduces new additions required for PLUVICTO,...
Finding the Right Patient for Lutetium-177 PSMA Treatment - Kara Cossis Details Phillip Koo converses with Kara Cossis about the critical aspect of patient selection for PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) treatment. Ms. Cossis outlines the criteria for identifying suitable candidates, emphasizing the role of castrate-resistant metastatic prostate cancer, disease burden, and eligibility based on scans. She also discusses the logistics of obtaining PSMA PET scans...
Coordinating & Transitioning Patient Care for Patients Who Receive Lutetium-177 - Elizabeth Davis Details Phillip Koo interviews Elizabeth Davis to discuss the crucial role of care coordination in the PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) program. Ms. Davis outlines the step-by-step process she follows once a physician decides a patient should receive PLUVICTO treatment. From handling paperwork and insurance approvals to ordering the drug and scheduling injections, Ms. Davis ensures a seam...
A Urologist’s Multidisciplinary Approach to Clinical Management of the Patient Receiving Lutetium-177 - Benjamin Lowentritt Details In this discussion, Phillip Koo interviews Benjamin Lowentritt about the complexities of integrating a PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) program into a large urology practice. Dr. Lowentritt emphasizes the value of patient selection, particularly for those who are post-chemotherapy. He outlines how his team manages the transition of patients from medical oncologists to their specia...
Radiation Safety Considerations for the Authorized User when Operationalizing Lutetium-177 in the Urology Clinic - Robert Brookland Details Phillip Koo converses with Robert Brookland about the intricacies of implementing a PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) program. Dr. Brookland, who serves as both the radiation safety officer and the authorized user, elaborates on the pivotal role of an authorized user in patient selection, treatment monitoring, and patient counseling. He also discusses the importance of experience w...
Multidisciplinary Transitions in Care for Patients Receiving Lutetium-177 - Benjamin Lowentritt & Robert Brookland Details Phillip Koo hosts Benjamin Lowentritt, Urologist, and Robert Brookland, Radiation Oncologist, to discuss the multidisciplinary approach to patient care with PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan). Dr. Lowentritt outlines the seamless transition from identifying suitable candidates for PLUVICTO to referring them to Dr. Brookland for further consultation and treatment. The discussion delv...